CIRCULARITY-FUNDED RESEARCH
PERFORMED BY HEALTHCARE EXPERTS
Title: New prospect of treatment of wound healing
- Researcher: Professor Puruhito
o Thoracic, cardiac and vascular surgery, medical faculty, Universitas Airlangga, Surabaya, Indonesia - Sample: Diabetic patients with ulcers identified as Wagner 1 to 3.
Most important findings:
- All diabetic foot ulcers evaluated during the study time period presented marked clinical improvements, and some patients gained total ulcer resolution.
Title: Complex treatment of complicated crural decollement injury in a diabetic patient
- Researchers: I. Gárgyán, Á. Csonka, K. Boa, E. Varga
o Department of Traumatology, University of Szeged, Hungary - Sample: Case presentation
Most important findings:
- A patient had a stage 4 ulcer with necrotic borders secondary to a car-accident-associated fracture with massive soft tissue contusion and crural decollement.
Results: The physician used the D’OXYVA® medical device as adjuvant therapy to save the patient’s limb from amputation and obtain complete ulcer resolution after 3 months of therapy.
Title: Transdermal delivery of carbon dioxide boosts microcirculation in subjects with and without diabetes
Researchers: Lee C. Rogers, D.P.M., Judy M. Muller-Delp, Ph.D., Topy A. Mudde, MSc.
- Sample: Healthy and diabetic patients
Most important findings:
- All of the flux parameters demonstrated marked improvement after the use of the D’OXYVA® device. The skin perfusion index increased after CO2 transdermal treatment. The diabetic participants demonstrated the most flux improvement after treatment, compared with healthy individuals. Both groups demonstrated improved blood pressure.
Title: Pilot study of D’OXYVA® transdermal gas delivery device in adult equines
Researchers: Dr. Karen Indreland, DVM
Sample: Healthy horses
Most important findings:
A D’OXYVA® device was used to provide high-concentration-CO2 water vapor, which increased microcirculation (flux) blood flow in the superficial skeletal muscle and skin of equines, compared with the control group.
Why can the D’OXYVA® medical device and its capacity to produce highly concentrated CO2 vapor improve general health care?
-
-
- It has natural anti-inflammatory characteristics.
-
-
-
- It increases blood flow through microcirculation, by arteriolar/venous dilatation.
-
-
-
- It produces a rightward shift in the O2 dissociation curve.
-
-
-
- It enhances oxygen delivery at the cellular level in the muscles, organs, brain, skin and other parts of the body.
-
-
-
- It is a fat-dissolving compound.
-
-
-
- It naturally sedates and calms the central nervous system.
-
-
-
- It can be used to reconstruct functionally closed capillaries.
-
-
-
- It can improve venous response.
-
-
-
- It improves blood-flow properties.
-
-
-
- It can be used to sedate the central nervous system.
-